AR047154A1 - TREATMENT OF INSOMNIA IN HUMAN PATIENTS ADMINISTRANDOLES A DAILY AMOUNT OF GABOXADOL - Google Patents
TREATMENT OF INSOMNIA IN HUMAN PATIENTS ADMINISTRANDOLES A DAILY AMOUNT OF GABOXADOLInfo
- Publication number
- AR047154A1 AR047154A1 ARP040104752A ARP040104752A AR047154A1 AR 047154 A1 AR047154 A1 AR 047154A1 AR P040104752 A ARP040104752 A AR P040104752A AR P040104752 A ARP040104752 A AR P040104752A AR 047154 A1 AR047154 A1 AR 047154A1
- Authority
- AR
- Argentina
- Prior art keywords
- insomnia
- treatment
- gaboxadol
- administrandoles
- daily amount
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Abstract
Un método para el tratamiento del insomnio en un paciente humano que lo necesita mediante la administracion a dicho paciente de una cantidad diaria de gaboxadol, cantidad que es efectiva para el tratamiento de insomnio. Reivindicacion 10: El uso del gaboxadol para la preparacion de un medicamento para el tratamiento del insomnio en un paciente humano, donde el medicamento se presenta en forma de dosis oral.A method for the treatment of insomnia in a human patient who needs it by administering to said patient a daily amount of gaboxadol, an amount that is effective for the treatment of insomnia. Claim 10: The use of gaboxadol for the preparation of a medicament for the treatment of insomnia in a human patient, wherein the medicament is presented as an oral dose.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301877 | 2003-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR047154A1 true AR047154A1 (en) | 2006-01-11 |
Family
ID=34684447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040104752A AR047154A1 (en) | 2003-12-18 | 2004-12-17 | TREATMENT OF INSOMNIA IN HUMAN PATIENTS ADMINISTRANDOLES A DAILY AMOUNT OF GABOXADOL |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1720547A1 (en) |
| JP (1) | JP2007515415A (en) |
| KR (1) | KR20060103335A (en) |
| CN (1) | CN1893942A (en) |
| AR (1) | AR047154A1 (en) |
| AU (1) | AU2004298313A1 (en) |
| BR (1) | BRPI0415893A (en) |
| CA (1) | CA2550610A1 (en) |
| EA (1) | EA200600989A1 (en) |
| IL (1) | IL176239A0 (en) |
| IS (1) | IS8390A (en) |
| MX (1) | MXPA06006685A (en) |
| NO (1) | NO20063320L (en) |
| SG (1) | SG133601A1 (en) |
| TW (1) | TW200528098A (en) |
| WO (1) | WO2005058313A1 (en) |
| ZA (1) | ZA200602762B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0402118D0 (en) | 2004-01-30 | 2004-03-03 | Merck Sharp & Dohme | Polymorphic forms of a GABAA agonist |
| EP1906953A4 (en) * | 2005-04-29 | 2009-05-20 | Lundbeck & Co As H | Acid and base salt forms of gaboxadol |
| EP3661507A4 (en) * | 2017-09-12 | 2020-11-18 | Ovid Therapeutics Inc. | Use of gaboxadol in the treatment of narcolepsy |
| JP2022501384A (en) | 2018-09-20 | 2022-01-06 | オービッド・セラピューティクス・インコーポレイテッドOvid Therapeutics Inc. | Use of gaboxador for the treatment of Tourette's syndrome, tics and stuttering |
| WO2020131856A1 (en) | 2018-12-17 | 2020-06-25 | Ovid Therapeutics Inc. | Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder |
| AU2020405060A1 (en) | 2019-12-18 | 2022-06-09 | Ovid Therapeutics Inc. | Gaboxadol for therapeutic treatment of 1p36 deletion syndrome |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19525598C2 (en) * | 1995-07-13 | 1997-09-25 | Max Planck Gesellschaft | sleeping pills |
| CN1511026A (en) * | 2001-05-21 | 2004-07-07 | H��¡�±�������˾ | Granular preparations of gaboxadol |
-
2004
- 2004-12-07 TW TW093137759A patent/TW200528098A/en unknown
- 2004-12-14 JP JP2006544213A patent/JP2007515415A/en not_active Withdrawn
- 2004-12-14 CA CA002550610A patent/CA2550610A1/en not_active Abandoned
- 2004-12-14 EP EP04803014A patent/EP1720547A1/en not_active Withdrawn
- 2004-12-14 AU AU2004298313A patent/AU2004298313A1/en not_active Abandoned
- 2004-12-14 ZA ZA200602762A patent/ZA200602762B/en unknown
- 2004-12-14 BR BRPI0415893-8A patent/BRPI0415893A/en not_active IP Right Cessation
- 2004-12-14 KR KR1020067011921A patent/KR20060103335A/en not_active Application Discontinuation
- 2004-12-14 EA EA200600989A patent/EA200600989A1/en unknown
- 2004-12-14 MX MXPA06006685A patent/MXPA06006685A/en unknown
- 2004-12-14 CN CNA2004800372437A patent/CN1893942A/en active Pending
- 2004-12-14 WO PCT/DK2004/000861 patent/WO2005058313A1/en active Application Filing
- 2004-12-14 SG SG200704528-9A patent/SG133601A1/en unknown
- 2004-12-17 AR ARP040104752A patent/AR047154A1/en not_active Application Discontinuation
-
2006
- 2006-03-30 IS IS8390A patent/IS8390A/en unknown
- 2006-06-11 IL IL176239A patent/IL176239A0/en unknown
- 2006-07-18 NO NO20063320A patent/NO20063320L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007515415A (en) | 2007-06-14 |
| MXPA06006685A (en) | 2006-08-23 |
| CN1893942A (en) | 2007-01-10 |
| NO20063320L (en) | 2006-07-18 |
| IS8390A (en) | 2006-03-30 |
| ZA200602762B (en) | 2007-06-27 |
| SG133601A1 (en) | 2007-07-30 |
| AU2004298313A1 (en) | 2005-06-30 |
| WO2005058313A1 (en) | 2005-06-30 |
| BRPI0415893A (en) | 2007-01-09 |
| EA200600989A1 (en) | 2006-10-27 |
| KR20060103335A (en) | 2006-09-28 |
| TW200528098A (en) | 2005-09-01 |
| IL176239A0 (en) | 2006-10-05 |
| EP1720547A1 (en) | 2006-11-15 |
| CA2550610A1 (en) | 2005-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1116727T1 (en) | Multiple Sclerosis Treatment With LAQUINIMOD | |
| NO20055880L (en) | Memantine oral dosage forms | |
| MX2009002196A (en) | Buprenophine-wafer for drug substitution therapy. | |
| AR050418A1 (en) | HER ANTIBODY FIXED DOSAGE | |
| PE20170302A1 (en) | USE OF PRIDOPIDINE IN HIGH DOSES FOR THE TREATMENT OF HUNTINGTON DISEASE | |
| AR065580A1 (en) | IMPROVEMENTS IN MEDICINAL COMPOSITIONS OR RELATED TO THE SAME | |
| PE20142319A1 (en) | MULTIPLE SCLEROSIS TREATMENT WITH A COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE | |
| ECSP045069A (en) | USE OF FLIBANSERINE IN THE TREATMENT OF SEXUAL DISORDERS | |
| JP2006501240A5 (en) | ||
| CO6150188A2 (en) | USE OF TEENCTEPLASA TO TREAT AN ACUTE ISCHEMICAL ICTUS | |
| AR090885A1 (en) | USE OF LAQUINIMOD IN HIGH DOSE FOR THE TREATMENT OF MULTIPLE SCLEROSIS | |
| AR054249A1 (en) | TREATMENT OF SKIN CONNECTIVE TISSUE DISEASES | |
| AR065581A1 (en) | IMPROVEMENTS IN MEDICINAL COMPOSITIONS OR RELATED TO THE SAME | |
| AR048318A1 (en) | ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA | |
| AR043259A1 (en) | METHOD FOR THE TREATMENT OF SEVERE CARDIAC INSUFFICIENCY AND MEDICATION FOR IT | |
| AR045783A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING A P2X7 RECEIVER ANTAGONIST AND AN NON-STEROID ANTI-INFLAMMATORY DRUG | |
| AR065582A1 (en) | IMPROVEMENTS IN MEDICINAL COMPOSITIONS OR RELATED TO THE SAME | |
| AR065139A1 (en) | MEDICATION FOR THE TREATMENT OF ENDOMETRIOSIS | |
| AR047154A1 (en) | TREATMENT OF INSOMNIA IN HUMAN PATIENTS ADMINISTRANDOLES A DAILY AMOUNT OF GABOXADOL | |
| AR027394A1 (en) | USE OF MIRTAZAPINE FOR THE TREATMENT OF SOIL DISORDERS | |
| ECSP066836A (en) | PIPERAZINAS DERIVED FROM UREA FOR THE TREATMENT OF ENDOMETROSIS | |
| DK1675611T3 (en) | Therapeutic uses for C-peptide | |
| NZ597675A (en) | Medicament for the long term nsaid use | |
| MX2010006310A (en) | O-desmethyl-venlafaxine for treating major depressive disorder. | |
| AR061046A1 (en) | MIRTAZAPINE FOR THE TREATMENT OF NEUROPATHIC PAIN |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |